We reviewed new psoriatic arthritis approvals as well as data readouts from head-to-head trials and milestone data in IgG4-related disease.
|Slideshows|September 21, 2018
Rheumatic Disease Awareness Month: Focus on Spinal Mobility in Ankylosing Spondylitis
A non-pharmacologic treatment may have wide-reaching benefits in AS, ranging from weight management to better spinal mobility.
Advertisement
Reference1. Sundström B, Ljung L, Wållberg-Jonsson S. Exercise habits and C-reactive protein may predict development of spinal immobility in patients with ankylosing spondylitis. Clin Rheumatol. 2018;37:2881-2885. doi: 10.1007/s10067-018-4195-y.
Advertisement
Related to this article
Key changes in the 2026 ACR/SAA/SPARTAN guideline update elevate JAK inhibitors to a strong recommendation and introduce nociplastic pain guidance.
Advertisement
Advertisement